The suggestion was made by the division bench of Chief Justice Mohit Shah and Justice MS Sanklecha while hearing a petition filed by one Rajdeep Deshmukh, claiming that the drug causes congenital deformity.
According to the petitioner, who himself suffers from the disorder which has affected two fingers each on both his hands, use of the drug is widely known to cause phocomelia (malformation of limbs).
"However, the doctor treating her prescribed the drug unaware about its consequences," the petition states.
While hearing the petition earlier this week, high court had directed that FDA be included as a respondent in the matter with a suggestion for it to consider issuing a circular regarding the drug for gynaecologists and obstetricians.
The matter has been posted for a hearing on Sept. 6.
Deshmukh had approached high court after the Special Medical Board certified that he was unfit for Health Science Courses.
It has asked the report for the above test to be submitted by Sept. 6.
Deshmukh's advocate Pooja Thorat argued that the functional capacity of his upper limb was very strong and he can carry out all routine activities without any difficulty.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
